Comparative efficacy of antiherpes drugs in different cell lines.
作者信息
De Clercq E
出版信息
Antimicrob Agents Chemother. 1982 Apr;21(4):661-3. doi: 10.1128/AAC.21.4.661.
Abstract
A selection of antiherpes compounds including bromovinyldeoxyuridine (BVDU), acyclovir (ACV), and fluoroiodoaracytosine (FIAC) were compared for their inhibitory effects on herpes simplex virus type 1 (strain KOS) replication in a wide variety of human, simian, feline, and murine cell lines. The 50% inhibitory doses of the compounds varied considerably from one cell line to another, i.e., from 0.01 to 2 micrograms/ml for ACV and from 0.004 to 0.2 micrograms/ml for BVDU and FIAC. However, the relative order of antiviral potency remained constant, thus (in order of decreasing potency) BVDU greater than FIAC greater than ACV, for all cell lines studied except for the murine embryo cells, in which the order of decreasing potency was BVDU greater than ACV greater than FIAC, and for the feline lung cells, in which the order of decreasing potency was FIAC greater than ACV greater than BVDU.
摘要
相似文献
1
Comparative efficacy of antiherpes drugs in different cell lines.
Antimicrob Agents Chemother. 1982 Apr;21(4):661-3. doi: 10.1128/AAC.21.4.661.
2
Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Am J Med. 1982 Jul 20;73(1A):40-8. doi: 10.1016/0002-9343(82)90061-4.
3
Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Antiviral Res. 1983 Sep;3(3):175-87. doi: 10.1016/0166-3542(83)90024-4.
4
Comparative activity of various compounds against clinical strains of herpes simplex virus.
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):143-51. doi: 10.1007/BF01967066.
5
Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains.
Tohoku J Exp Med. 1986 Mar;148(3):275-83. doi: 10.1620/tjem.148.275.
6
Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Acta Virol. 1984 Jan;28(1):1-10.
7
Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
Antimicrob Agents Chemother. 1985 Dec;28(6):740-4. doi: 10.1128/AAC.28.6.740.
8
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Antiviral Res. 1985 Jun;5(3):169-77. doi: 10.1016/0166-3542(85)90049-x.
9
[Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
Biull Eksp Biol Med. 1987 Oct;104(10):490-2.
10
Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.
Antimicrob Agents Chemother. 1985 Jun;27(6):971-3. doi: 10.1128/AAC.27.6.971.
引用本文的文献
1
In vitro antiviral efficacy of amenamevir against feline herpesvirus 1.
J Vet Med Sci. 2025 Aug 1;87(8):906-910. doi: 10.1292/jvms.25-0086. Epub 2025 Jun 24.
2
Antiviral and virucidal activities of Duabanga grandiflora leaf extract against Pseudorabies virus in vitro.
BMC Complement Altern Med. 2016 May 23;16:139. doi: 10.1186/s12906-016-1120-2.
3
Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses.
Antimicrob Agents Chemother. 2005 Nov;49(11):4671-80. doi: 10.1128/AAC.49.11.4671-4680.2005.
4
Safety of famciclovir in patients with herpes zoster and genital herpes.
Antimicrob Agents Chemother. 1994 Oct;38(10):2454-7. doi: 10.1128/AAC.38.10.2454.
5
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.
Antimicrob Agents Chemother. 1983 Sep;24(3):353-61. doi: 10.1128/AAC.24.3.353.
6
Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Antimicrob Agents Chemother. 1984 Aug;26(2):155-9. doi: 10.1128/AAC.26.2.155.
7
Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds.
Antimicrob Agents Chemother. 1984 Apr;25(4):417-21. doi: 10.1128/AAC.25.4.417.
8
Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine.
Antimicrob Agents Chemother. 1983 Nov;24(5):819-22. doi: 10.1128/AAC.24.5.819.
9
Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
Antimicrob Agents Chemother. 1983 Jun;23(6):808-13. doi: 10.1128/AAC.23.6.808.
10
Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Biochem J. 1983 May 1;211(2):439-45. doi: 10.1042/bj2110439.
本文引用的文献
1
Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
Antiviral Res. 1981 Nov;1(4):213-23. doi: 10.1016/0166-3542(81)90012-7.
2
Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Antimicrob Agents Chemother. 1981 Jul;20(1):47-52. doi: 10.1128/AAC.20.1.47.
3
2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
Antimicrob Agents Chemother. 1980 May;17(5):803-6. doi: 10.1128/AAC.17.5.803.
4
The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.
J Antimicrob Chemother. 1979 Jul;5(4):431-6. doi: 10.1093/jac/5.4.431.
5
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947-51. doi: 10.1073/pnas.76.6.2947.
6
9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.
Nature. 1978 Apr 13;272(5654):583-5. doi: 10.1038/272583a0.
7
Nucleoside-catabolizing enzyme activities in primary rabbit kidney cells and human skin fibroblasts.
Biochem Pharmacol. 1978 May 15;27(10):1421-6. doi: 10.1016/0006-2952(78)90095-3.
Zotero 插件